Jingyan Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Cross Sectional

Coronavirus Disease

Chronic Lymphocytic Leukemia

Top Venues

Expert review of vaccines

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Jingyan Yang, Kristen Markus, Kathleen Michelle Andersen, Abby E Rudolph, Leah J McGrath, Jennifer L Nguyen, Moe H Kyaw, Isabelle Whittle, Vasileios Blazos, Louise Heron, Julia Regazzini Spinardi
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ open 14 (1) (2024)
Jingyan Yang, Kristen Markus, Kathleen Michelle Andersen, Abby E Rudolph, Leah J McGrath, Jennifer L Nguyen, Moe H Kyaw, Isabelle Whittle, Vasileios Blazos, Louise Heron, Julia Regazzini Spinardi
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ open 14 (1) (2024)
Jingyan Yang, Kristen Markus, Kathleen Michelle Andersen, Abby E Rudolph, Leah J McGrath, Jennifer L Nguyen, Moe H Kyaw, Isabelle Whittle, Vasileios Blazos, Louise Heron, Julia Regazzini Spinardi
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ open 14 (1) (2024)
Jingyan Yang, Kristen Markus, Kathleen Michelle Andersen, Abby E Rudolph, Leah J McGrath, Jennifer L Nguyen, Moe H Kyaw, Isabelle Whittle, Vasileios Blazos, Louise Heron, Julia Regazzini Spinardi
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ open 14 (1) (2024)
Jingyan Yang, Kristen Markus, Kathleen Michelle Andersen, Abby E Rudolph, Leah J McGrath, Jennifer L Nguyen, Moe H Kyaw, Isabelle Whittle, Vasileios Blazos, Louise Heron, Julia Regazzini Spinardi
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ open 14 (1) (2024)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2023)
Manuela Di Fusco, Diana Mendes, Lotte Steuten, David E Bloom, Michael Drummond, Katharina Hauck, Jonathan Pearson-Stuttard, Rachel Power, David Salisbury, Adrian Towse, Julie Roiz, Gabor Szabo, Jingyan Yang, Kinga Marczell
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines 11 (2) (2023)
Manuela di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L Wiemken, Jingyan Yang, Benjamin Yarnoff
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (original and omicron BA.4/BA.5) in the United States. Journal of medical economics (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Manuela Di Fusco, Diana Mendes, Lotte Steuten, David E Bloom, Michael Drummond, Katharina Hauck, Jonathan Pearson-Stuttard, Rachel Power, David Salisbury, Adrian Towse, Julie Roiz, Gabor Szabo, Jingyan Yang, Kinga Marczell
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines 11 (2) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Jingyan Yang, Guilherme Cordeiro, Mauricio Longato, Shailja Vaghela, Moe H Kyaw, Carlos Fernando Mendoza, Ana Dantas, Thais Senna, Pedro Holanda, Julia Regazzini Spinardi
Burden of COVID-19 during the omicron predominance in Brazil: a nationwide retrospective database study. Journal of medical economics (2023)
Paul Cornes, John Kelton, Rongzhe Liu, Omer Zaidi, Jennifer M Stephens, Jingyan Yang
Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia. Future oncology (London, England) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe H Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Diana Mendes, Ruth Chapman, Peter Gal, Jessica Atwell, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021. Journal of medical economics 25 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe H Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines (2022)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2022)
Ahmed Shelbaya, John M Kelton, Jeffrey Thompson, Jose Mj Alvir, Martine C Maculaitis, Jingyan Yang
Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA. Future oncology (London, England) 17 (30) (2021)
Jingyan Yang, Kelly Blinzler, Joshua Lankin, Sapna Vijayakumar, Martine C Maculaitis, Ahmed Shelbaya
Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
Jingyan Yang, Rongzhe Liu, Anna Granghaud, Omer Zaidi, Jennifer M Stephens
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data. Journal of medical economics 24 (1) (2021)